ROHTO PHARMACEUTICAL CO.,LTD.JP:4527

Market cap
¥704.5B
P/E ratio
22.6x
Mar 31,
2013
Mar 31,
2014
Mar 31,
2015
Mar 31,
2016
Mar 31,
2017
Mar 31,
2018
Mar 31,
2019
Mar 31,
2020
Mar 31,
2021
Mar 31,
2022
Mar 31,
2023
Profit (loss) before income taxes13,63014,59913,75114,30314,75216,82016,30021,73023,00627,95334,290
Depreciation5,2565,7356,0596,0445,5525,5936,1596,0586,3767,2327,418
Impairment losses1,6154625401,0521,609892965
Amortization of goodwill192191282404371321245879372457383
Increase (decrease) in allowance for doubtful accounts-27201717362-15164-63-233-139164
Increase (decrease) in provision for bonuses1154-14121129194-8234-44288481
Increase (decrease) in retirement benefit liability-121425847-695-456-382-663847727
Bad debt expense-OpeCF5302505492755703102502041,1241,158422
Loss on retirement of non-current assets17215182153
Loss on tax purpose reduction entry of non-current assets110220
National subsidies-OpeCF-110-128-220
Gain on bargain purchase-430
Loss (gain) on sale of investment securities-1,391-454-71-1,329-1,973-29-76-15
Loss (gain) on valuation of investment securities644472524574711,1791,2631,484642103
Loss on valuation of shares of subsidiaries and associates7713096522456285502232197
Interest and dividend income-484-567-605-658-718-678-752-994-1,393-752-1,424
Interest expenses180165231166135143148125145248247
Share of loss (profit) of entities accounted for using equity method15-167-1574421957822,4041,192-396-143-56
Loss (gain) on change in equity-37-125
Decrease (increase) in trade receivables1,432-365-3,634-13,1891,274-2,8185,342-4,3042,464-30-7,560
Decrease (increase) in inventories-656-1,090354-1,390-827-2,186-4,3598923,188-2,743-6,105
Increase (decrease) in trade payables-8841,087-2,4363,2841653,094-984-900-2,8113,3231,716
Other, net9373,1462,0991,189-2,457771853-444-5,272-6345,461
Subtotal21,74824,20116,14613,34818,95323,76927,46424,76928,26837,09336,747
Interest and dividends received4475325536807226827541,0181,3907381,362
Interest paid-187-195-217-174-141-147-150-130-143-228-247
Payments for guarantee obligations-1,735-1,622
Income taxes paid-5,306-5,877-5,471-2,957-6,140-5,169-5,984-6,644-7,798-8,823-6,962
Income taxes refund342735193327279225
Net cash provided by (used in) operating activities16,70218,66111,29211,32413,42819,15421,74519,04020,00827,25030,924
Payments into time deposits-566-1,056-835-552-924-886-692-1,918-1,523
Proceeds from withdrawal of time deposits41,0839065558467396349631,265
Purchase of property, plant and equipment-5,130-6,278-3,964-4,563-3,777-5,000-6,416-5,586-8,721-10,267-8,473
Proceeds from sale of property, plant and equipment352,12859712109
Payments for asset retirement obligations-42
Purchase of intangible assets-273-431-183-168-203-452-501-847-1,583-1,061-1,435
Purchase of investment securities-2,449-5,205-940-2,382-7,092-5,246-3,045-2,700-1,514-3,697-4,417
Proceeds from sale and redemption of investment securities1,0402,1581,92273,6153,4161,0001,376
Purchase of shares of subsidiaries resulting in change in scope of consolidation-760-3,836-5,755-1,516-1,203
Subsidies received110128220
Long-term loan advances-2,483-2,291-308-926-730-373-341-343-966-404-258
Proceeds from collection of long-term loans receivable43118108412
Other, net-414-5-262-13206121502
Net cash provided by (used in) investing activities-10,595-12,620-9,024-6,066-9,511-11,014-10,245-9,405-10,237-16,406-13,176
Net increase (decrease) in short-term borrowings8043,283-433-3,370-750479-91-2,649-1691,273-1,341
Proceeds from long-term borrowings9931026611,1235911015,0322,8839,450220
Repayments of long-term borrowings-2,292-2,031-1,280-1,190-678-333-646-714-1,880-3,133-8,761
Dividends paid-1,881-2,116-2,050-2,278-2,278-2,506-2,506-3,078-2,965-3,422-4,676
Dividends paid to non-controlling interests-18-1-8-20
Purchase of shares of subsidiaries not resulting in change in scope of consolidation-200-489-762
Other, net-35-21-47-44-20-39-41-184-214-208-857
Net cash provided by (used in) financing activities-3,408-5,211-3,375-5,898-2,335-1,823-3,386-1,603-2,3473,470-16,199
Effect of exchange rate change on cash and cash equivalents1,7421,8492,775-1,998-633-191-832-781964,3355,236
Net increase (decrease) in cash and cash equivalents4,4412,6781,667-2,6389476,1257,2817,2507,51918,6506,786